Research summary ·
The impact of metabolic syndrome on major adverse cardiovascular events (MACE) in young adults with acute coronary syndrome: a GRADED systematic review and meta-analysis.
Written based on 1 research study on PubMed, searched on 12 Nov 2026.
What was studied
This review asked how metabolic syndrome, or MetS, affects young adults. These adults had acute coronary syndrome. The adults were younger than 45 or 50 years. The authors searched PubMed, Google Scholar and CENTRAL up to June 2026. They pooled observational studies. The main outcomes were major adverse cardiovascular events, or MACE, repeat heart attack and stroke. In all, 3,691,728 people were included.
What they found
MetS was linked to more MACE. The risk ratio was 1.93, with a range of 1.83-2.03. Repeat heart attack was also more likely, with a ratio of 2.08. Stroke risk was higher too, at 2.33. Follow-up length and diagnostic criteria explained some differences between studies. The certainty of the evidence was moderate for all main outcomes.
What it means for patients
The authors say MetS predicts worse heart outcomes in young survivors of acute coronary syndrome. They say this shows the need for early risk checks and active metabolic care.
Why it is not certain yet
A small number of studies were pooled, though they were large. All were observational, so they show links, not cause. The range for repeat heart attack was wide, from 1.17 to 3.68. A review can only be as good as the studies in it.
Source
The impact of metabolic syndrome on major adverse cardiovascular events (MACE) in young adults with acute coronary syndrome: a GRADED systematic review and meta-analysis.
PubMed · PMID 43000246We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Coronary artery disease publications